Ranked #1
New therapies vie to change fatal course of amyotrophic lateral sclerosis
New therapies vie to change fatal course of amyotrophic lateral sclerosis
As multidisciplinary care extends survival and improves the quality of life for people with amyotrophic lateral sclerosi... Read more
3 Jun 2022
•
33mins
Ranked #2
Biopharma’s correction? 2022 1Q investments are both up and down
Biopharma’s correction? 2022 1Q investments are both up and down
Could investments in biopharmaceutical companies in 2022 be as aggressive as 2021, which saw a record 1,968 biopharma de... Read more
2 May 2022
•
17mins
Similar Podcasts
The Top Line
The Readout Loud
The Daily
Up First
The Remnant with Jonah Goldberg
Ranked #3
Who advises the CDC on big COVID decisions and how’s that working out?
Who advises the CDC on big COVID decisions and how’s that working out?
The CDC’s Advisory Committee on Immunization Practices (ACIP) always had a full schedule, but COVID-19 amped it up treme... Read more
23 Feb 2022
•
24mins
Ranked #4
Long COVID: Potentially the next public health crisis
Long COVID: Potentially the next public health crisis
With the study of long COVID-19 continuing to evolve, the BioWorld team is taking a closer look at the condition -- a co... Read more
14 Feb 2022
•
23mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
What happens when your inventor is an artificial intelligence?
What happens when your inventor is an artificial intelligence?
The increasing use of artificial intelligence (AI) technologies across all stages of drug development is presenting inte... Read more
14 Dec 2021
•
29mins
Ranked #6
Another record year for biopharma financings bodes well for 2022
Another record year for biopharma financings bodes well for 2022
In another record year for biopharma fundraisings, more money than ever pulsed through the industry. The volume and valu... Read more
9 Dec 2021
•
18mins
Ranked #7
Aduhelm’s hard lessons and what it means for other Alzheimer’s drugs
Aduhelm’s hard lessons and what it means for other Alzheimer’s drugs
The FDA’s June 2021 approval of Aduhelm (aducanumab), the first plaque-targeting therapy, rattled the company, regulator... Read more
9 Dec 2021
•
32mins
Ranked #8
Supply Chain Geeky: Managing through the challenges of COVID-19 with an eye to what’s at stake
Supply Chain Geeky: Managing through the challenges of COVID-19 with an eye to what’s at stake
Complex manufacturing processes and supply chains have always been part of the biopharma industry story, with many peopl... Read more
9 Dec 2021
•
23mins
Ranked #9
Regulatory Gemish: COVID-19’s big impacts on the FDA and beyond
Regulatory Gemish: COVID-19’s big impacts on the FDA and beyond
Amid industry’s ongoing drive to speed drug discovery, clinical development and commercial success, government regulatio... Read more
9 Dec 2021
•
28mins
Ranked #10
Reality check: How did industry develop COVID-19 vaccines and drugs so fast?
Reality check: How did industry develop COVID-19 vaccines and drugs so fast?
The COVID-19 pandemic is so all encompassing and complex, with dramatic details shifting almost hourly, that it can be e... Read more
26 Oct 2021
•
16mins
